Latest Breaking News On - Meditrina institute of medical sciences - Page 3 : vimarsana.com

AIIMS Delhi to begin clinical trials for COVID-19 vaccine on 6-12 age group from Tuesday

The clinical trials will try to evaluate the safety, reactogenicity and immunogenicity of Bharat Biotech's Covaxin jabs in children.

New delhiIndia instituteMeditrina institute of medical sciencesAll india institute of medical sciencesBharat biotechMeditrina instituteMedical sciencesCovid 19Aiims delhiLinical trials for 6 12 age groupOvid vaccine clinical trials for 6 12 age groupCoronavirus vaccine dosesCovid 19 vaccine dosesபுதியது டெல்ஹிஇந்தியா நிறுவனம்மேதிற்றின நிறுவனம் ஆஃப் மருத்துவ அறிவியல்

Covaxin trials start on 2-18 age set at six cities - The Hindu BusinessLine

Covaxin trials start on 2-18 age set at six cities - The Hindu BusinessLine
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

United kingdomNew delhiAndhra pradeshUttar pradeshZydus cadilaMysore medical collegeResearch instituteMeditrina institute of medical sciencesMember healthIndia institute of medical sciencesAll india instituteMedical sciencesCheluvambha hospitalDrugs controller generalMeditrina institutePrakhar hospital

AIIMS Delhi to screen children for Covaxin trials from Monday | India News

India News: NEW DELHI: All India Institute Of Medical Sciences (AIIMS) Delhi will start screening children for the indigenous Covaxin trials from Monday, news age.

India instituteMeditrina institute of medical sciencesAll india institute of medical sciencesDrugs controller generalMeditrina instituteMedical sciencesNdia newsNdia news todayOday newsGoogle newsReaking newsDrugs controllerஇந்தியா நிறுவனம்மேதிற்றின நிறுவனம் ஆஃப் மருத்துவ அறிவியல்அனைத்தும் இந்தியா நிறுவனம் ஆஃப் மருத்துவ அறிவியல்மருந்துகள் கட்டுப்படுத்தி ஜநரல்

Which COVID Vaccines Will be Available for Kids, Are Nasal Sprays Better: All Your FAQs Answered

The Pfizer-BioNTech COVID-19 vaccine is the first and only vaccine in the world, so far, to have been approved for the 12-15 age group.

Andhra pradeshUnited kingdomUttar pradeshZydus cadilaTedros adhanom ghebreyesusUniversity of hong kongCoalition for epidemic preparedness innovationsSerum research instituteJawaharlal nehru medical collegeSerum institute of indiaAdvisory committee on immunization practiceDepartment of paediatricsAligarh muslim universityDrug administrationIndian council of medical researchMeditrina institute of medical sciences

COVID-19: Covaxin clinical trials for children begin at AIIMS Patna

Updated: Jun 3, 2021, 08:40 AM IST The paediatric trials for the COVID-19 vaccine manufactured by the Bharat Biotech, Covaxin has started at Patna`s All India Institute of Medical Sciences (AIIMS). Covaxin received the Drugs Controller General of India (DCGI) nod to conduct clinical trials in children on May 11. Dr VK Paul, Member (Health), Niti Aayog had earlier said, Covaxin has been approved by the Drugs Controller General of India (DCGI), for Phase II/III clinical trials in the age group of 2 to 18 years. The Covaxin trials are also slated to take place in 525 subjects at various sites, including AIIMS, Delhi, and Meditrina Institute of Medical Sciences, Nagpur.

India institute of medical sciencesMember healthMeditrina institute of medical sciencesBharat biotechAll india instituteMedical sciencesDrugs controller generalNiti aayogMeditrina instituteCovid 19 vaccineCovaxin trials for childrenCovaxin clinical trialsCovaxin for childrenCovaxin vaccineBharat biotech covaxinBharat biotech india limited